Fundz

Turn Therapeutics launches public investment campaign to fund clinical trials for eczema and toenail fungus treatment

PUBLIC · TTRXMay 23, 2024

Round Type

Venture

Westlake VillageBiotechnologyHealth CarePharmaceuticalpharmaceuticals

Description

Turn Therapeutics, an innovative biotech company, has launched its first public investment campaign today to fund clinical trials of its FDA-cleared antimicrobial ointment for treating moderate to severe eczema and onychomycosis (toenail fungus). The company aims to invite public investment to support the expansion of its flagship wound formula into eczema and toenail fungus treatments.

Who else raised in Pharmaceutical and pharmaceuticals around the same time

Companies in the same sectors as Turn Therapeutics Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
  • N-Power Medicine raised $72M (Series B) on July 1, 2024.
  • Phlow raised $5M on June 28, 2024.
  • CASI Pharmaceuticals raised $15M (Post-IPO Equity) on June 26, 2024.
  • Formation Bio raised $372M (Series D) on June 26, 2024.
  • CASI Pharmaceuticals raised $15M on June 26, 2024.

Who to call at Turn Therapeutics Inc., and when

A new round usually means Turn Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Turn Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Turn Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Turn Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Turn Therapeutics Inc.

Location

250 N. Westlake Blvd.

Westlake Village, California, United States

About

Turn Therapeutics® is a concept to approval pharmaceutical and medical device organization dedicated to reducing the human and economic costs of infection and skin disease. Turn Therapeutics® was founded with a goal of reducing antibiotic resistance through best in class acute and chronic wound care products. Through research and development, we have continued to uncover additional disease areas that our technology will serve. Our core mission is to leverage our expertise in drug delivery to create disruptive products for high need indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Turn Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAngbeen C., Chief of Staff hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Turn Therapeutics Inc.'s next move

See what Strategic adds

Turn Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.